(November 14, 2012) Gardasil genetic fingerprints found in postmortem samples of girls given vaccine

A recent study published in the open-access journal Pharmaceutical Regulatory Affairs provides shocking new evidence that viral components contained in the human papillomavirus (HPV) vaccine Gardasil are capable of crossing the blood-brain barrier and triggering cerebral vasculitis, a severe form of blood vessel inflammation in the brain that can lead to severe autoimmune disorders and even death.

A postmortem assessment of two young girls from opposite ends of the world who died recently after being given the Gardasil vaccine revealed fragments of the HPV-16L1 antigen, which is added to both Gardasil (Merck & Co.) and Cervarix (GlaxoSmithKline), inside the girls' brain tissue.

According to the study's authors, these particles represent a genetic fingerprint of the Gardasil vaccine, which is now clearly exposed as causing serious, adverse events in at least some of the girls that receive it.